The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The release of the adipocytokine visfatin is regulated by glucose and insulin
Open accessAbstract
Aims/hypothesis The novel insulin-mimetic adipocytokine visfatin has been linked to the metabolic syndrome, but its regulation has not been characterised to date. Since insulin-mimetic actions of visfatin may be part of the feedback regulation of glucose homeostasis, we hypothesised that visfatin concentrations are influenced by glucose or insulin blood levels in humans.Subjects, materials and methods In this randomised, double-blind, placebo-controlled crossover study, nine healthy male subjects (age 26+/-6 years) attended three different study days. On each day, systemic glucose concentrations of 5.0, 8.3 and 11.1 mmol/l were attained by stepwise increases in i.v. infusions of glucose, representing fasting and postprandial conditions. Visfatin plasma concentrations were studied during concomitant exogenous hyperinsulinaemia, inhibition of endogenous insulin production by somatostatin infusion, and placebo time control. Additionally, human adipocytes were cultured to study visfatin release and mRNA expression in vitro.Results Glucose concentrations of 8.3 and 11.1 mmol/l increased circulating visfatin from baseline concentrations of 0.5+/-0.0 ng/ml to 0.9+/-0.1 and 2.1+/-0.3 ng/ml, respectively (p<0.01). Glucose-induced elevation of visfatin was prevented by co-infusion of insulin or somatostatin (p<0.05). Cultured subcutaneous and visceral adipocytes released an equivalent amount of visfatin upon glucose-concentration- and time-dependent stimulation. Visfatin secretion involved the phosphatidylinositol 3-kinase (PI3-kinase) and protein kinase B (AKT) pathways. The mRNA expression pattern of visfatin was consistent with this altered protein release.Conclusions/interpretation Circulating visfatin concentrations are increased by hyperglycaemia. This effect is suppressed by exogenous hyperinsulinaemia or somatostatin infusion. Glucose signalling for visfatin release in adipocytes involves the PI3-kinase/AKT pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, metformin may alleviate abnormal visfatin levels in PCOS patients by increasing peripheral insulin sensitivity and thereby decreasing the IR-induced hyperinsulinemia, which, in turn, may lower visfatin secretion because insulin and glucose affect visfatin secretion via the phosphatidylinositol 3-kinase/protein kinase B pathway (55).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedLeptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,061
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081
Plasma Visfatin Concentrations and Fat Depot–Specific mRNA Expression in Humans
Berndt, J., Klöting, N., Kralisch, S., Kovacs, P. L., Faßhauer, M., Schön, M. R., Stümvoll, M., & Blüher, M. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2911 · Cited by 733
Chen, M., Chung, F., Chang, D., Tsai, J. C. ‐., Huang, H.-F., Shin, S., & Lee, Y. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1475 · Cited by 660
Haider, D. G., Schindler, K., Schaller, G., Prager, G., Wolzt, M., & Ludvik, B. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2248 · Cited by 310
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 257
The role of visfatin (PBEF/Nampt) in pregnancy complications
Pavlová, T., Novák, J., & Vašků, J. B. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.09.004 · Cited by 33
Mazaki‐Tovi, S., Vaisbuch, E., Romero, R. J., Kusanovic, J. P., Chaiworapongsa, T., Kim, S. K., Nhan‐Chang, C., Gómez, R., Savasan, Z. A., Madan, I., et al. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903572190 · Cited by 33
Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome
Lin, C., Lai, M.-M., Li, T., Li, C.-I., Liu, C.-S., Chen, C., & Wu, M. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.016 · Cited by 33
Central Nervous System Circuitry Involved in the Hyperinsulinism Syndrome
Lechín, F., & van der Dijs, B. (2006) · Neuroendocrinology · doi:10.1159/000098005 · Cited by 33
Αλεξιάδου, Κ., Kokkinos, A. D., Liatis, S., Perrea, D. N., Katsilambros, N. L., & Tentolouris, N. (2012) · HORMONES · doi:10.14310/horm.2002.1376 · Cited by 32
Bayani, M., Pourali, M., & Keivan, M. (2017) · European Journal of Dentistry · doi:10.4103/ejd.ejd_284_16 · Cited by 32
Non-canonical roles of NAMPT and PARP in inflammation
Martínez-Morcillo, F. J., Cantón-Sandoval, J., Martínez‐Menchón, T., Corbalán-Vélez, R., Mesa-del-Castillo, P., Pérez‐Oliva, A. B., García‐Moreno, D., & Mulero, V. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103881 · Cited by 33
Plasma Visfatin Concentrations in Subjects with Type 1 Diabetes Mellitus
Törüner, F. B., Altınova, A. E., Bukan, N. C., Arslan, E., Akbay, E., Ersoy, R., & Arslan, M. (2009) · Hormone Research in Paediatrics · doi:10.1159/000224338 · Cited by 32
Plasma visfatin levels in preeclamptic and normal pregnancies
Zülfikaroğlu, E., İşman, F. K., Payaslı, A., Kiliç, S., Kücür, M., & Danışman, N. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1192-z · Cited by 32
Akbarzadeh, S., Nabipour, I., Jafari, S. M., Movahed, A., Motamed, N., Assadi, M., & Hajian, N. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.004 · Cited by 32
Job stress related to glyco‐lipid allostatic load, adiponectin and visfatin
Li, W., Zhang, J., Sun, J., Ke, J., Dong, Z., & Wang, S. (2007) · Stress and Health · doi:10.1002/smi.1145 · Cited by 31
Plasma Visfatin Is Increased after High-Intensity Exercise
Ghanbari–Niaki, A., Saghebjoo, M., Soltani, R., & Kirwan, J. P. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000313936 · Cited by 30
Olarescu, N. C., Ueland, T., Lekva, T., Dahl, T. B., Halvorsen, B. L., Aukrust, P., & Bollerslev, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2417 · Cited by 30
Srinivasan, M., Meadows, M. L., & Maxwell, L. (2018) · Biochemistry Research International · doi:10.1155/2018/7463796 · Cited by 34
Salemi, Z., rafie, E., Goodarzi, M. T., & Ghaffari, M. A. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.23814 · Cited by 29
Can adipokine visfatin be a novel marker of pregnancy‐related disorders in women with obesity?
Wnuk, A., Stangret, A., Wątroba, M., Platek, A. E., Skoda, M., Cendrowski, K., Sawicki, W., & Szukiewicz, D. (2020) · Obesity Reviews · doi:10.1111/obr.13022 · Cited by 32
Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome
Tarkun (2010) · PubMed · doi:10.1684/ecn.2010.0217 · Cited by 28
Kováčiková, M., Vitkova, M., Klimčáková, E., Polak, J., Hejnová, J., Bajzová, M., Kováčová, Z., Viguerie, N., Langin, D., & Štich, V. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01964.x · Cited by 28
Ooi, D. S. Q., Chan, R. M. E., Poh, L. K. S., Loke, K. Y., Heng, C., Chan, Y. H., Gan, S. U., Lee, K., & Lee, Y. S. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00149.x · Cited by 27
The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
Schindler, K., Vila, G., Hoppichler, F., Lechleitner, M., Luger, A., Anderwald, C. H., Hoefler, J., Tomasec, G., Kautzky‐Willer, A., & Ludvik, B. H. (2012) · Obesity Facts · doi:10.1159/000338729 · Cited by 27
Self-citationOlszanecka‐Glinianowicz, M., Owczarek, A. J., Bożentowicz‐Wikarek, M., Brzozowska, A., Mossakowska, M., Zdrojewski, T. R., Grodzicki, T. K., Więcek, A., & Chudek, J. T. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.013 · Cited by 27
The comparison of serum vaspin and visfatin concentrations in obese and normal weight women
Saboori, S., Hosseinzadeh‐Attar, M. J., Rad, E. Y., Hosseini, M., Mirzaei, K., & Ahmadivand, Z. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.10.009 · Cited by 27
Visfatin regulates genes related to lipid metabolism in porcine adipocytes
Yang, C. C. C.-C., Deng, S. J., Hsu, C.-C., Liu, B. H., Lin, E. C., Cheng, W. T. K., Wang, P. H., & Ding, S. (2010) · Journal of Animal Science · doi:10.2527/jas.2010-2799 · Cited by 27
Intensive Glycemic Control Lowers Plasma Visfatin Levels in Patients with Type 2 Diabetes
Zhu, J., Schott, M., Liu, R., Liu, C., Shen, B., Wang, Q., Mao, X., Xu, K., Wu, X., Schinner, S., et al. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082040 · Cited by 27
Role of visfatin, insulin-like growth factor-I and insulin in fetal growth
Briana, D. D., Boutsikou, M., Gourgiotis, D., Kontara, L., Baka, S. G., Iacovidou, N. M., Hassiakos, D., & Malamitsi‐Puchner, A. (2007) · Journal of Perinatal Medicine · doi:10.1515/jpm.2007.071 · Cited by 27
The Correlation of Prediabetes and Type 2 Diabetes With Adiposity in Adults
Sun, J., Liu, Z., Zhang, Z., Zeng, Z., & Kang, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.818263 · Cited by 27
Serum visfatin in Asian women with polycystic ovary syndrome
Jongwutiwes, T., Lertvikool, S., Leelaphiwat, S., Rattanasiri, S., Jultanmas, R., & Weerakiet, S. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015478 · Cited by 26
Meral, C., Çekmez, F., Pirgon, Ö., Tanju, İ. A., İpçioğlu, O. M., Karademır, F., & Göçmen, İ. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.482604 · Cited by 25
Zheng, X., Wang, W., Zhang, L., Su, C.-F., Wu, Y.-Y., Ke, Y., Hou, Q.-W., Liu, Z., Gao, A.-S., & Feng, W. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12035 · Cited by 25
Hsieh, C., He, C.-T., Lee, C.-H., Wu, L., & Hung, Y. (2007) · Metabolism · doi:10.1016/j.metabol.2007.03.018 · Cited by 25
Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM
Souvannavong-Vilivong, X., Sitticharoon, C., Klinjampa, R., Keadkraichaiwat, I., Sripong, C., Chatree, S., Sririwichitchai, R., & Lertbunnaphong, T. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01355-0 · Cited by 24
Kaygusuz, İ., Gümüş, İ. İ., Yılmaz, S., Simavlı, S. A., Uysal, S., Derbent, A. U., Gözdemir, E., & Kafalı, H. C. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000348560 · Cited by 25
Ünlütürk, U., Harmancı, A., Yıldız, B. O., & Bayraktar, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03674.x · Cited by 23
Friebe, D., Löffler, D., Schönberg, M., Bernhard, F., Buttner, P. G., Landgraf, K., Kieß, W., & Körner, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019526 · Cited by 24
Nüsken, K., Petrasch, M., Rauh, M., Stöhr, W., Nüsken, E., Schneider, H., & Dötsch, J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp178 · Cited by 23
Poljšak, B. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1975 · Cited by 24
de Luis, D. A., Sagrado, M. G., Aller, R., Conde, R., & Izaola, O. (2009) · Nutrition · doi:10.1016/j.nut.2008.11.019 · Cited by 23
Pedro, W. J. S., Júnior, F. V. B., Alves, F. N. B. R., Braga, L. V., Alves, L. R., Afonso, J. P. R., Silva, I. O., Silva, C. H. M., Vencio, S. A. C., Capodaglio, P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13102321 · Cited by 27
Visfatin concentrations in patients with endometrial cancer
Avcıoğlu, S. N., Altınkaya, S. Ö., Küçük, M., Yüksel, H., Ömürlü, İ. K., & Yanık, S. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.975687 · Cited by 23
Adiponectin, visfatin and regional fat depots in normal weight obese premenopausal women
Miazgowski, T., Safranow, K., Krzyżanowska‐Świniarska, B., Iskierska, K., & Widecka, K. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12106 · Cited by 22
Gunduz, F. O., Yıldırmak, S., Temizel, M., Faki, Y., Çakmak, M., Durmuşcan, M., & Sezgin, F. H. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.523 · Cited by 21
Coşkun, A., Özkaya, M., Kıran, G., Kılınç, M., & Arıkan, D. C. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903551426 · Cited by 21
Belo, V. D. A., Luizon, M. R., Lacchini, R., de Miranda, J. A., Lanna, C. M. M., Souza-Costa, D. C., & Tanus-Santos, J. E. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.173 · Cited by 20
Manoharan, B., Bobby, Z., Dorairajan, G., Vinayagam, V., & Packirisamy, R. M. (2019) · Saudi Medical Journal · doi:10.15537/smj.2019.4.24058 · Cited by 21
Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis
Jiang, Y.-K., Deng, H., Qiao, Z., & Gong, F. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1874997 · Cited by 20
Kocełak, P., Olszanecka‐Glinianowicz, M., Owczarek, A. J., Bożentowicz‐Wikarek, M., Brzozowska, A., Mossakowska, M., Zdrojewski, T. R., Grodzicki, T. K., Więcek, A., & Chudek, J. T. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.11.002 · Cited by 20
Szymańska, K., Zaobidna, E., Rytelewska, E., Mlyczyńska, E., Kurowska, P., Dobrzyń, K., Kieżun, M., Kamińska, B., Smolińska, N., Rak, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45255-4 · Cited by 21
Hajianfar, H., Bahonar, A., Entezari, M. H., Askari, G., & Yazdani, M. (2012) · Europe PMC (PubMed Central) · Cited by 19
Gao, Y., Wang, C., Pan, T., & Luo, L. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002840 · Cited by 19
Tond, S. B., Fallah, S., Salemi, Z., & Seifi, M. (2016) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2016160297 · Cited by 19
Haider, D. G., & Wolzt, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0405-2 · Cited by 19
Self-citationStangret, A., Dykacz, W., Jabłoński, K., Wesolowska, A. M., Klimczak‐Tomaniak, D., Kochman, J., & Tomaniak, M. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.08.009 · Cited by 18
Bone marrow stem cell-derived β-cells: New issue for diabetes cell therapy.
Aglan, H., Kotob, S. E., Mahmoud, N., Kishta, M., & Ahmed, H. H. (2023) · Tissue & Cell · doi:10.1016/j.tice.2023.102280 · Cited by 18
Kotnik, P., Fischer‐Posovszky, P., & Wabitsch, M. (2015) · Slovenian Journal of Public Health · doi:10.1515/sjph-2015-0020 · Cited by 17
Yang, R., Chang, L., Liu, S., Jin, X., & Li, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2408 · Cited by 17
Çekmez, F., Canpolat, F. E., Pirgon, Ö., Aydemir, G., Tanju, İ. A., Genc, F. A., Tunç, T., Aydınöz, S., Yıldırım, Ş., İpçioğlu, O. M., et al. (2013) · PubMed · Cited by 17
Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats
Demir, Ş., Ünübol, M., Aypak, S. Ü., İpek, E., Aktaş, S., Aşıcı, G. S. E., Yılmaz, M., Tunca, R., & Güney, E. (2016) · International Journal of Endocrinology · doi:10.1155/2016/5083746 · Cited by 17
Gender dimorphic increase in RBP ‐4 and NGAL in children born after IVF : an epigenetic phenomenon?
Sakka, S. D., Margeli, A., Loutradis, D., Chrousos, G. P., Papassotiriou, I., & Kanaka‐Gantenbein, C. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12066 · Cited by 16
Mlyczyńska, E., Zaobidna, E. A., Rytelewska, E., Dobrzyń, K., Kieżun, M., Kopij, G., Szymańska, K., Kurowska, P., Dall’Aglio, C., Smolińska, N., et al. (2023) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2023.107212 · Cited by 15
Analytic Review: Glucose Controversies in the ICU
Honiden, S., & Inzucchi, S. E. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610387892 · Cited by 15
Erten, Y., Ebinç, F. A., Ebinç, H., Paşaoğlu, H., Demirtaş, C., Taçoy, G. A., Koç, E., Derici, Ü., Reis, K. A., Bali, M., et al. (2008) · Renal Failure · doi:10.1080/08860220802134573 · Cited by 15
Owczarek, A. J., Olszanecka‐Glinianowicz, M., Kocełak, P., Bożentowicz‐Wikarek, M., Brzozowska, A., Mossakowska, M., Puzianowska‐Kuźnicka, M., Grodzicki, T. K., Więcek, A., & Chudek, J. T. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2016.1230884 · Cited by 14
Liang, Z., Ying, W., & Danqing, C. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.020 · Cited by 14
Visfatin in pregnancy: proposed mechanism of peptide delivery
Katwa, L. C., & Seidel, E. R. (2008) · Amino Acids · doi:10.1007/s00726-008-0194-7 · Cited by 14
Serum Visfatin Is Differentially Regulated by Insulin and Free Fatty Acids in Healthy Men
Kowalska, I., Karczewska‐Kupczewska, M., Adamska, A., Nikołajuk, A., Otziomek, E., & Strączkowski, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2818 · Cited by 13
Dalamaga, Μ., & Christodoulatos, G. S. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41677-9_6 · Cited by 12
Mazaki‐Tovi, S., Romero, R. J., Vaisbuch, E., Kim, S. K., Kusanovic, J. P., Chaiworapongsa, T., Mittal, P., Dong, Z., Pacora, P., Yeo, L., et al. (2010) · Journal of Perinatal Medicine · doi:10.1515/jpm.2010.045 · Cited by 12
Mohammadi, S., Hosseinzadeh‐Attar, M. J., Hossein‐Nezhad, A., Hosseini, S. H., Eshraghian, M. R., Nezhad, M. K., Rahmani, M., & Karimi, M. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.02.014 · Cited by 11
Dysregulated adipokines in the pathogenesis of type 2 diabetes and vascular disease
Brown, J. E. P. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412464794 · Cited by 11
Matinhomaee, H., Borojeni, J. B., Azarbayjani, M. A., & Zolaktaf, V. (2014) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2014.01.001 · Cited by 11
Effects of different levels of physical inactivity on plasma visfatin in healthy normal-weight men
Rudwill, F., Blanc, S., Gauquelin‐Koch, G., Choukèr, A., Heer, M. A., Simon, C., & Bergouignan, A. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0434 · Cited by 11
Insulin reduces LPS-induced lethality and lung injury in rats
Liu, M.-L., Dong, H., Zhang, B., Wan-song, Z., Zhao, P., Liu, Y., Niu, W., Xu, D.-Q., & Li, Z. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.09.002 · Cited by 11
de Luis, D. A., Sagrado, M. G., Conde, R., Aller, R., Izaola, O., Mj, C., & Romero, E. (2010) · PubMed · Cited by 11
The Role of Visfatin in Pregnancy, Complications and Procreation
Marseglia, L. M., D’Angelo, G., Cuppari, C., Salpietro, V., Filippelli, M., Chirico, V., Gitto, E., Salpietro, C. D., Arrigo, T., & Manti, S. (2015) · Journal of Pediatric Biochemistry · doi:10.1055/s-0035-1554783 · Cited by 10
Stadler, M., Storka, A., Theuer, E. A., Krebs, M., Vojtassakova, E., Nowotny, P., Pacini, G., Kästenbauer, T., Luger, A., Prager, R., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03709.x · Cited by 10
Self-citationMartynowicz, H., Gać, P., Kornafel-Flak, O., Filipów, S., Łaczmański, Ł., Sobieszczańska, M. I., Mazur, G. J., & Poręba, R. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.12.012 · Cited by 9
Tabandeh, M. R., Taha, A. S., Ali, H. A., Jalali, M. H. R., & Mohammadtaghvaei, N. (2023) · Biomedicines · doi:10.3390/biomedicines11020346 · Cited by 9
de Luis, D. A., Izaola, O., Conde, R., Primo, D., Sagrado, M. G., & Aller, R. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2010.08.008 · Cited by 9
Kamińska, A., Kopczyńska, E., Bieliński, M. K., Borkowska, A., & Junik, R. (2015) · Endokrynologia Polska · doi:10.5603/ep.2015.0016 · Cited by 9
Kocełak, P., Olszanecka‐Glinianowicz, M., Owczarek, A. J., Krupa, W., Obirek, P., Bożentowicz‐Wikarek, M., Brzozowska, A., Mossakowska, M., Zdrojewski, T. R., Skalska, A., et al. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2878 · Cited by 9
Correlation of salivary visfatin levels in obese and NON-OBESE population with periodontal status
Rajasekar, A. (2022) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2022.11.004 · Cited by 9
de Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., Conde, R., & Romero, E. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.283 · Cited by 9
Visfatin as a predictor for growth of fetus and infant
Taraqi, A. S. M., Tehranian, N., Roudbaneh, S. P., Esmaeilzadeh, M. S., Kazemnejad, A., Aghoozi, M. F., & Yousefi, S. (2018) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.48091 · Cited by 9
Serum visfatin concentration in acutely ill and weight-recovered patients with anorexia nervosa
Seidel, M., King, J. A., Ritschel, F., Döpmann, J., Bühren, K., Seitz, J., Roessner, V., Westphal, S., Egberts, K. M., Burghardt, R., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.12.010 · Cited by 8
Tayebi, S. M., Saeidi, A., & Khosravi, M. (2016) · Annals of Applied Sport Science · doi:10.18869/acadpub.aassjournal.4.4.21 · Cited by 8
Pfützner, A., & Forst, T. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0391-4 · Cited by 8
Relationship between blood peroxidases activity and visfatin levels in metabolic syndrome patients.
Samsam-Shariat, S. Z., Bolhasani, M., Sarrafzadegan, N., Najafi, S., & Asgary, S. (2014) · Europe PMC (PubMed Central) · Cited by 7
Visfatina en pacientes obesos, relación con factores de riesgo cardiovascular, un estudio tranversal
de Luis, D. A., Ballesteros-Pomar, M. D., Ruiz, E., Muñoz, C., Penacho, Á., Iglesias, P., Guzman, A. L., Abreu, C., Maldonado, A., Delgado‐Rodríguez, M., et al. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2010.09.033 · Cited by 7
Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome
Orbetzova, M. M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90749 · Cited by 7
ADIPOKINES AND PATHOPHYSIOLOGY OF PREGNANCY COMPLICATIONS – THE ROLE OF LEPTIN AND ADIPONECTIN
Mazaki‐Tovi, S., Vaisbuch, E., & Romero, R. J. (2013) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539514000011 · Cited by 7
Zhu, Z., & Liu, Q. (2015) · Europe PMC (PubMed Central) · Cited by 6
Evaluation of the serum visfatin and adiponectin levels in patients with type 2 diabetes mellitus
Kara, M., Uslu, S., Kebapçı, N., Özçelik, E. Y., & Bal, C. (2014) · Turkish Journal of Biochemistry · doi:10.5505/tjb.2014.87487 · Cited by 6
Çatak, Z., Yavuzkır, Ş., Koçdemir, E., Uğur, K., Yardım, M., Şahin, İ., Agirbas, E. P., & Aydın, S. (2019) · Europe PMC (PubMed Central) · Cited by 6
Xu, F., Ning, X., Zhao, T., Lu, Q., & Chen, H. (2022) · Open Medicine · doi:10.1515/med-2022-0540 · Cited by 5
Al‐Sowayan, N. S. (2015) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2015.83018 · Cited by 5
Visfatin and TGF-Β1 in primary biliary cirrhosis and two other common liver diseases.
Waluga, M., Kukla, M., Żorniak, M., Kochel-Jankowska, A., Kajor, M., Krzemiński, T. F., & Kotulski, R. (2015) · PubMed · Cited by 5
The effect of n-fatty acid (omega 3) on serum visfatin concentration in patients with type2 diabetes
Hosseinzadeh‐Attar, M. J., Hajianfar, H., Bahonar, A., Mohamad, K., Keshavarz, S. A., Entezari, M. H., & Askari, G. (2012) · Pars of Jahrom University of Medical Sciences · doi:10.29252/jmj.10.1.26 · Cited by 5
Vascular dysfunction: a Janus face of visfatin in diabetes?
Teoh, H., Lovren, F., & Verma, S. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.002 · Cited by 5
Measuring visfatin levels in saliva: an alternative approach to gestational diabetes screening
Icli, H. E., & Bıldacı, T. B. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000396 · Cited by 4
Öztürk, N. K., Çiçek, B., Tekin, T., Güntürk, İ., Yazıcı, C., Karaca, Z., & Sönmez, M. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108550 · Cited by 4
Metadata
- Authors
- Haider, D. G., Schaller, G., Kapiotis, S., Maier, C., Luger, A., & Wolzt, M.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Wolzt, M.
- ORCID
- Wolzt, M.
- Venue
- Diabetologia
- Published
- 2006-05-31
- Volume
- 49
- Issue
- 8
- Pages
- 1909-1914
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1985941542
- Cited by
- 258
- References
- 23
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 12 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 5 · 2018: 9 · 2017: 5 · 2016: 11 · 2015: 18 · 2014: 14 · 2013: 20 · 2012: 14
- FWCI
- 18.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- 8th European Congress of Endocrinology incorporating the British Endocrine Societies
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- visfatin, adipokines, glucose homeostasis, hyperinsulinemia, hyperglycemia, somatostatin, adipocytes, PI3K/Akt signaling, insulin signaling, metabolic syndrome
- MeSH terms
- Insulin Secretion, Adult, Blood Glucose, Double-Blind Method, Glucose, Humans, Hyperinsulinism, Infusions, Intravenous, Insulin, Male, Placebos, Reference Values, Somatostatin, Cytokines, Adipocytes, Cross-Over Studies, Nicotinamide Phosphoribosyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review